Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M807Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M-155.4EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)17.9Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book2.610-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %0.9PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M14,600,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with PJP

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

PJP is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!

PJP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Rapps, MichaelDirector, Director or Senior Officer of 10% Securi 2017-01-16Buy1,200$9.48482.91view
Gridley, Anthony RonaldSenior Officer 2017-01-16Sell1,800$16.94226.21view
DINWOODIE, TYLER WAYNE PAULSenior Officer 2017-01-16Buy4,000$0.1732405.88view
Brown, Mark ThomasDirector 2017-01-16Sell29,300$1.363963.24view
Bebek, IvanDirector 2017-01-16Buy8,990$3.381534.91view
smith, laurie james10% Security Holder, Director, Senior Officer 2017-01-16Buy7,500$0.4113378.05view
MEHR, JEFFREYSenior Officer 2017-01-13Sell50,000$27.9197.99view
Squibb, Geoffrey WayneDirector 2017-01-13Buy267$6.27781.34view
Smith, DavidSenior Officer 2017-01-13Sell15,000$60.38-8.48view
Rowlands, William BruceDirector, Senior Officer 2017-01-13Buy20,000$0.1536740view

Quarterly/Annual Reports about PJP:

    News about PJP:

    Articles On GuruFocus.com
    4 Stocks Reach Their 3-Year Lows Jan 21 2017 
    A Fond Farewell Jan 21 2017 
    Insider Buys Highlight for the Week of Jan. 20 Jan 21 2017 
    US Market Indexes Lower for the Week Jan 21 2017 
    John Rogers Comments on JLL Jan 20 2017 
    John Rogers Comments on Charles River Laboratories Intl Jan 20 2017 
    John Rogers Comments on Keysight Technologies Jan 20 2017 
    John Rogers Comments on Thermo Fisher Scientific Inc. Jan 20 2017 
    John Rogers Comments on Zimmer Biomet Holdings Jan 20 2017 
    John Rogers Comments on Northern Trust Corp Jan 20 2017 

    More From Other Websites
    What Lies Ahead for Pharma ETFs? Jan 19 2017
    Trending: Pound Gains as Theresa May Lays out Brexit Plan Jan 19 2017
    Mylan’s Profit Margins: What Made Them Change? Jan 13 2017
    Understanding Mylan’s Revenues Jan 12 2017
    Harvoni: Gilead Sciences’ Blockbuster HCV Drug Jan 03 2017
    How Could Pfizer Drive Growth for Ibrance? Dec 12 2016
    Pisani: Trump rally is evolving Dec 07 2016
    Two Nano-Cap Pharma Stocks To Watch Right Now Dec 02 2016
    Understanding Merck’s Most Recent Product Developments Dec 01 2016
    How Baxter Continues to Contribute to Patient Care Dec 01 2016
    Steady Rise: Allergan’s International Segment in 3Q16 Nov 30 2016
    How Did Gilead Sciences’s HCV Business Perform across Geographies? Nov 29 2016
    How Was Bristol-Myers Squibb’s Profitability in 3Q16? Nov 29 2016
    Gilead Sciences Holds a Broader HIV Portfolio Nov 28 2016
    Bristol-Myers Squibb Continues Revenue Growth in 3Q16 Nov 25 2016
    Key Investor Insights into Eli Lilly’s Recent Developments Nov 25 2016
    Beyond Oncology: BMY’s Eliquis, a Key Growth Driver Nov 23 2016
    Understanding Eli Lilly’s Business Segments by 3Q16 Performance Nov 22 2016
    Inside Bristol’s Key to Success: Multiple Labels for Opdivo Nov 22 2016
    Understanding Bristol’s Blockbuster: Opdivo’s Edge over Keytruda Nov 18 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)